InvestorsHub Logo
Followers 92
Posts 5943
Boards Moderated 0
Alias Born 09/30/2005

Re: Alan Brochstein post# 13667

Monday, 05/23/2016 2:41:27 PM

Monday, May 23, 2016 2:41:27 PM

Post# of 21833
ALAN, if the DEA re-classifies from schedule 1, that would suggest a greatly increasing of cannabis testing for medical and other purposes.

If the re-classification were to happen, would this be a significant positive event for PAZOO, or are factors like management and finances just far too onerous/limiting for the company to grow and mak Pazoo a somewhat realistic high risk investment?
Many thanks.